Importantly, when IKKβ in the livers of NAFLD mice was silenced by siRNA, NF-κB signaling was not activated, and inflammation and liver fat metabolism were subsequently improved, verifying that NF-κB signaling is a downstream signal of IKKβ. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.